Shopping Cart 0
Cart Subtotal
USD 0

Europe PDX Models Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 3200
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Europe PDX models market was valued at USD 26.95 million in 2017 and growing at a lucrative rate of CAGR in the assessment period. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

The key market players for Europe PDX models market are listed below:

Crown Bioscience Inc.

The Jackson Laboratory

Champion Oncology, Inc.

Charles River

Oncodesign

Wuxi AppTec

Horizon Discovery Group plc

Pharmatest Services

Hera Biolabs

EPO Berlin-Buch GmbH

Xentech

Urolead

Creative Animodel

EUROPDX

MI Bioresearch Inc

Aragen Bioscience

The market is further segmented into:

Type

Tumor Type

Application

End User

The Europe PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.

The Europe PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.

The Europe PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.

The Europe PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.

Based on geography, the market is segmented into:

Germany

France

U.K.

Spain

Italy

Switzerland

Netherlands

Russia

Turkey

Belgium

Rest of Europe

Covered in this report

The report covers the present scenario and the growth prospects of the Europe PDX models market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Table Of Content

Scope

Table Of Contents

1 Introduction 11

1.1 Objectives Of The Study 11

1.2 Market Definition 11

1.3 Overview Of Europe Pdx Models Market 11

1.4 Currency And Pricing 12

1.5 Limitation 12

1.6 Markets Covered 12

2 Market Segmentation 14

2.1 Markets Covered 14

2.2 Geographic Scope 15

2.3 Years Considered For The Study 15

2.4 Currency And Pricing 16

2.5 Research Methodology 17

2.6 Primary Interviews With Key Opinion Leaders 20

2.7 Secondary Sources 21

2.8 Assumptions 21

3 Market Overview 22

3.1 Drivers 24

3.1.1 Rising Number Of Pharmaceutical R&D Activities In Cancer Research 24

3.1.2 Pdx Models Offer Advantages As Compared With The Classic Approach 26

3.1.3 Rising Need For Personalized Medicine 27

3.1.4 Increasing Support For Cancer Research Activities From Government And Non-Government Organization 27

3.2 Restraints 28

3.2.1 High Cost Of Pdx Models 28

3.2.2 Strict Regulation With Respect To The Utilization Of Animal Models In Cancer Research 28

3.3 Opprtunities 29

3.3.1 Increasing Demand For Humanized Pdx Models 29

3.4 Challenges 30

3.4.1 Limitations Of Pdx Models 30

4 Executive Summary 31

5 Premium Insights 33

6 Europe Pdx Models Market, By Type 36

6.1 Overview 37

6.2 Mice Models 39

6.3 Rat Models 40

7 Europe Pdx Models Market, By Tumor Type 41

7.1 Overview 42

7.2 Gastrointestinal Tumor Models 44

7.3 Gynecological Tumor Models 45

7.4 Respiratory Tumor Models 46

7.5 Urological Tumor Models 47

7.6 Hematological Tumor Models 48

7.7 Others 49

8 Europe Pdx Models Market, By Application 50

8.1 Overview 51

8.2 Preclinical Drug Development And Oncology Research 53

8.3 Biomarker Analysis 54

9 Europe Pdx Models Market, By End User 55

9.1 Overview 56

9.2 Contract Research Organizations 58

9.3 Pharmaceutical And Biotechnology Companies 59

9.4 Academic And Research Institutions 60

10 Europe Pdx Models Market, By Geography 61

10.1 Europe 61

10.1.1 Germany 70

10.1.2 France 72

10.1.3 U.K. 74

10.1.4 Italy 76

10.1.5 Spain 78

10.1.6 Switzerland 80

10.1.7 Netherlands 82

10.1.8 Turkey 84

10.1.9 Belgium 86

10.1.10 Russia 88

10.1.11 Rest Of Europe 90

11 Europe Pdx Models Market, Company Landscape 91

11.1 Company Share Analysis: Europe 91

12 Company Profiles 92

12.1 Charles River 92

12.1.1 Company Overview 92

12.1.2 Revenue Analysis 92

12.1.3 Company Share Analysis 93

12.1.4 Product Portfolio 93

12.1.5 Recent Developments 93

12.2 Crown Bioscience Inc. (Subsidiary Of Jsr Corporation) 94

12.2.1 Company Overview 94

12.2.2 Geographic Presence 94

12.2.3 Company Share Analysis 95

12.2.4 Product Portfolio 95

12.2.5 Recent Developments 96

12.3 Champion Oncology, Inc 97

12.3.1 Company Overview 97

12.3.2 Revenue Analysis 97

12.3.3 Company Share Analysis 98

12.3.4 Product Portfolio 98

12.3.5 Recent Developments 98

12.4 Aragen Bioscience (Subsidiary Of Gvk Biosciences Private Limited) 99

12.4.1 Company Overview 99

12.4.2 Product Portfolio 99

12.4.3 Recent Developments 99

12.5 Creative Animodel 100

12.5.1 Company Overview 100

12.5.2 Product Portfolio 100

12.5.3 Recent Developments 100

12.6 Epo Berlin-Buch Gmbh 101

12.6.1 Company Overview 101

12.6.2 Product Portfolio 101

12.6.3 Recent Developments 101

12.7 Europdx 102

12.7.1 Company Overview 102

12.7.2 Geographical Presence 102

12.7.3 Product Portfolio 103

12.7.4 Recent Developments 103

12.8 Hera Biolabs 104

12.8.1 Company Overview 104

12.8.2 Product Portfolio 104

12.8.3 Recent Developments 104

12.9 Horizon Discovery Group Plc 105

12.9.1 Company Overview 105

12.9.2 Revenue Analysis 105

12.9.3 Product Portfolio 106

12.9.4 Recent Developments 106

12.10 Mi Bioresearch Inc 107

12.10.1 Company Overview 107

12.10.2 Product Portfolio 107

12.10.3 Recent Developments 107

12.11 Oncodesign 108

12.11.1 Company Overview 108

12.11.2 Revenue Analysis 108

12.11.3 Product Portfolio 109

12.11.4 Recent Developments 109

12.12 Pharmatest Services Ltd 110

12.12.1 Company Overview 110

12.12.2 Geographic Presence 110

12.12.3 Product Portfolio 111

12.12.4 Recent Developments 111

12.13 The Jackson Laboratory 112

12.13.1 Company Overview 112

12.13.2 Revenue Analysis 112

12.13.3 Product Portfolio 113

12.13.4 Recent Developments 113

12.14 Urolead 114

12.14.1 Company Overview 114

12.14.2 Product Portfolio 114

12.14.3 Recent Developments 114

12.15 Wuxi Apptec 115

12.15.1 Company Overview 115

12.15.2 Geographic Presence 115

12.15.3 Product Portfolio 116

12.15.4 Recent Developments 116

12.16 Xentech 117

12.16.1 Company Overview 117

12.16.2 Product Portfolio 117

12.16.3 Recent Developments 117

13 Related Reports 118


List Of Figure

List Of Figures

Figure 1 Europe Pdx Models Market: Segmentation 14

Figure 2 Europe Pdx Models Market: Data Triangulation 17

Figure 3 Europe Pdx Models Market: Research Snapshot 18

Figure 4 Europe Pdx Models Market : Bottom Up Approach 19

Figure 5 Europe Pdx Models Market : Top Down Approach 19

Figure 6 Europe Pdx Models Market: Interview Demographics 20

Figure 7 Drivers, Restraints, Opportunities, And Challenges Of Pdx Models Market 23

Figure 8 Below Mentioned Is R&D Expense By The Jackson Laboratory For Year 2016-17: 25

Figure 9 Europe Pdx Models Market: Segmentation 32

Figure 10 Rising Number Of Pharmaceutical R&D Activities In Cancer Research And Rising Need For Personalized Medicine Are Expected To Drive The Market For Pdx Models In The Forecast Period 2018 To 2025 33

Figure 11 Mice Models Is Expected To Account For The Largest Share Of The Europe Pdx Models Market In 2018 & 2025 34

Figure 12 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Pdx Models Market In The Forecast Period From 2018 To 2025 35

Figure 13 Europe Pdx Models Market: By Type, 2017 37

Figure 14 Europe Pdx Models Market: By Tyumor Type, 2017 42

Figure 15 Europe Pdx Models Market: By Application, 2017 51

Figure 16 Europe Pdx Models Market: By End User, 2017 56

Figure 17 Europe Pdx Models Market Snapshot (2017) 61

Figure 18 Europe Pdx Models Market: By Country (2017) 63

Figure 19 Europe Pdx Models Market: By Country (2018 & 2025) 64

Figure 20 Europe Pdx Models Market: By Country (2017 & 2025) 65

Figure 21 Europe Pdx Models Market: By Type (2018-2025) 66

Figure 22 Europe Pdx Models Market: Company Share 2017 (%) 91


List Of Table

List Of Tables

Uu

Table 1 Europe Pdx Models Market, By Type, 2016- 2025, (Usd Million) 38

Table 2 Europe Mice Models In Pdx Models Market, By Region, 2016-2025, (Usd Million) 39

Table 3 Europe Rat Models In Pdx Models Market, By Region, 2016-2025, (Usd Million) 40

Table 4 Europe Pdx Models Market, By Tumor Type, 2016- 2025 (Usd Million) 43

Table 5 Europe Gastrointestinal Tumor Models Market, By Region, 2016-2025, (Usd Million) 44

Table 6 Europe Gynecological Tumor Models Market, By Region, 2016-2025, (Usd Million) 45

Table 7 Europe Respiratory Tumor Models Market, By Region, 2016-2025, (Usd Million) 46

Table 8 Europe Urological Tumor Models Market, By Region, 2016-2025, (Usd Million) 47

Table 9 Europe Hematological Tumor Models Market, By Region, 2016-2025, (Usd Million) 48

Table 10 Europe Others Tumor Types In Pdx Models Market, By Region, 2016-2025, (Usd Million) 49

Table 11 Europe Pdx Models Market, By Application, 2016- 2025 (Usd Million) 52

Table 12 Europe Preclinical Drug Development And Oncology Research In Pdx Models Market, By Region, 2016-2025, (Usd Million) 53

Table 13 Europe Biomarker Analysis In Pdx Models Market, By Region, 2016-2025, (Usd Million) 54

Table 14 Europe Pdx Models Market, By End User, 2016- 2025, (Usd Million) 57

Table 15 Europe Contract Research Organizations In Pdx Model Market, By Region, 2016-2025, (Usd Million) 58

Table 16 Europe Pharmaceutical And Biotechnology Companies In Pdx Models Market, By Region, 2016-2025, (Usd Million) 59

Table 17 Europe Academic And Research Institutions In Pdx Modela Market, By Region, 2016-2025, (Usd Million) 60

Table 18 Europe Pdx Models Market, By Country , 2016-2025 (Usd Million) 67

Table 19 Europe Pdx Models Market, By Type, 2016-2025, (Usd Million) 68

Table 20 Europe Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 68

Table 21 Europe Pdx Models Market, By Application, 2016-2025, (Usd Million) 69

Table 22 Europe Pdx Models Market, By End User, 2016-2025, (Usd Million) 69

Table 23 Germany Pdx Models Market, By Type, 2016-2025, (Usd Million) 70

Table 24 Germany Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 70

Table 25 Germany Pdx Models Market, By Application, 2016-2025, (Usd Million) 71

Table 26 Germany Pdx Models Market, By End User, 2016-2025, (Usd Million) 71

Table 27 France Pdx Models Market, By Type, 2016-2025, (Usd Million) 72

Table 28 France Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 72

Table 29 France Pdx Models Market, By Application, 2016-2025, (Usd Million) 73

Table 30 France Pdx Models Market, By End User, 2016-2025, (Usd Million) 73

Table 31 U.K. Pdx Models Market, By Type, 2016-2025, (Usd Million) 74

Table 32 U.K. Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 74

Table 33 U.K. Pdx Models Market, By Application, 2016-2025, (Usd Million) 75

Table 34 U.K. Pdx Models Market, By End User, 2016-2025, (Usd Million) 75

Table 35 Italy Pdx Models Market, By Type, 2016-2025, (Usd Million) 76

Table 36 Italy Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 76

Table 37 Italy Pdx Models Market, By Application, 2016-2025, (Usd Million) 77

Table 38 Italy Pdx Models Market, By End User, 2016-2025, (Usd Million) 77

Table 39 Spain Pdx Models Market, By Type, 2016-2025, (Usd Million) 78

Table 40 Spain Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 78

Table 41 Spain Pdx Models Market, By Application, 2016-2025, (Usd Million) 79

Table 42 Spain Pdx Models Market, By End User, 2016-2025, (Usd Million) 79

Table 43 Switzerland Pdx Models Market, By Type, 2016-2025, (Usd Million) 80

Table 44 Switzerland Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 80

Table 45 Switzerland Pdx Models Market, By Application, 2016-2025, (Usd Million) 81

Table 46 Switzerland Pdx Models Market, By End User, 2016-2025, (Usd Million) 81

Table 47 Netherlands Pdx Models Market, By Type, 2016-2025, (Usd Million) 82

Table 48 Netherlands Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 82

Table 49 Netherlands Pdx Models Market, By Application, 2016-2025, (Usd Million) 83

Table 50 Netherlands Pdx Models Market, By End User, 2016-2025, (Usd Million) 83

Table 51 Turkey Pdx Models Market, By Type, 2016-2025, (Usd Million) 84

Table 52 Turkey Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 84

Table 53 Turkey Pdx Models Market, By Application, 2016-2025, (Usd Million) 85

Table 54 Turkey Pdx Models Market, By End User, 2016-2025, (Usd Million) 85

Table 55 Belgium Pdx Models Market, By Type, 2016-2025, (Usd Million) 86

Table 56 Belgium Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 86

Table 57 Belgium Pdx Models Market, By Application, 2016-2025, (Usd Million) 87

Table 58 Belgium Pdx Models Market, By End User, 2016-2025, (Usd Million) 87

Table 59 Russia Pdx Models Market, By Type, 2016-2025, (Usd Million) 88

Table 60 Russia Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 88

Table 61 Russia Pdx Models Market, By Application, 2016-2025, (Usd Million) 89

Table 62 Russia Pdx Models Market, By End User, 2016-2025, (Usd Million) 89

Table 63 Rest Of Europe Pdx Models Market, By Type, 2016-2025, (Usd Million) 90

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Crown Bioscience Inc.

The Jackson Laboratory

Champion Oncology, Inc.

Charles River

Oncodesign

Wuxi AppTec

Horizon Discovery Group plc

Pharmatest Services

Hera Biolabs

EPO Berlin-Buch GmbH

Xentech

Urolead

Creative Animodel

EUROPDX

MI Bioresearch Inc

Aragen Bioscience